← All trials
NCT07224711
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2026
- Primary completion
- May 30, 2028
- Completion date
- May 30, 2028
- First posted
- Nov 5, 2025
- Last posted
- Nov 5, 2025
- Enrollment
- 2290
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Vanderbilt UniversityLead sponsor
- Vanderbilt UniversitySponsor investigator
- Vanderbilt UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.